Deep Dive • Pre-IPO • $DXYZ
THE VELVET ROPE
IS NOW A TICKER
DXYZ gives retail investors a seat at the private tech table — SpaceX, Anthropic, OpenAI — before the IPO bell rings.
For decades, the most valuable companies in the world — the ones minting billionaires in Silicon Valley conference rooms — were completely off-limits to you. Venture capital was a club with no public entrance. DXYZ is the door someone finally left open.
Destiny Tech100 is a closed-end fund listed on the NYSE since March 2024. Think of it like a mutual fund built in a VC firm's back office — it acquires equity stakes in late-stage, venture-backed private companies and packages them into a single ticker you can buy on any brokerage account. No accredited investor status required. No $250K minimum. Just a market order.
Top holdings as of the most recent reporting period:
That's SpaceX, the company reportedly filing its IPO prospectus imminently with advisers eyeing a valuation near $1.75 trillion — potentially the largest IPO in history. It's OpenAI, running nearly $20 billion in annual revenue and reportedly eyeing a late-2026 listing. It's Databricks, valued at over $130 billion in its last funding round. And it's Anthropic — the AI lab that needs no introduction. These are the company's institutional investors fight to get allocation in. DXYZ lets you get there first.
The thesis plays out in stages. When one of these companies files for an IPO, DXYZ's stated value of that position re-prices — often dramatically upward. Investors holding DXYZ are essentially pre-positioned ahead of Day 1 retail pricing, without scrambling for shares in an oversubscribed offering. As the IPO pipeline heats up across the portfolio, every listing is a potential catalyst for the fund's NAV and stock price.
The stock has responded accordingly — and so has the dilution. DXYZ ran hard recently, jumping 21% on May 8 and another 30% on May 11 on SpaceX IPO momentum, touching a 52-week high near $71. Then today hit $54 as the market digested news of an increased share offering. That's the DXYZ pattern in a nutshell: explosive upside, then the ATM offering steps in and bleeds the rally.
The NAV premium. The fund's net asset value was reported at ~$19.97 per share as of December 2025. At $54 today — after the pullback — you're still paying nearly 3x stated NAV. That premium exists because the market believes the private valuations are stale and that SpaceX alone will reprice everything upward at IPO. If the IPO delays, that premium compresses.
The fee drag. A 4.98% annual expense ratio is steep. Over a multi-year hold, it compounds against you. Factor it in.
None of that makes DXYZ uninvestable. It makes it a trader's instrument more than a buy-and-hold. The $54 level after an offering-driven flush is actually the setup worth watching — historically, DXYZ bounces hard once the dilution overhang gets absorbed and the next IPO headline drops.
Watch the offering activity closely. When DXYZ runs, check whether Jefferies is hitting the ask with new share sales — that's your signal on whether the rally has legs or is about to get bled again. The thesis is intact. The timing is the trade.
No comments:
Post a Comment